211 related articles for article (PubMed ID: 23114620)
1. Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.
Marchan R; Lesjak MS; Stewart JD; Winter R; Seeliger J; Hengstler JG
Cell Cycle; 2012 Dec; 11(24):4499-506. PubMed ID: 23114620
[TBL] [Abstract][Full Text] [Related]
2. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
Stewart JD; Marchan R; Lesjak MS; Lambert J; Hergenroeder R; Ellis JK; Lau CH; Keun HC; Schmitz G; Schiller J; Eibisch M; Hedberg C; Waldmann H; Lausch E; Tanner B; Sehouli J; Sagemueller J; Staude H; Steiner E; Hengstler JG
Proc Natl Acad Sci U S A; 2012 May; 109(21):8155-60. PubMed ID: 22570503
[TBL] [Abstract][Full Text] [Related]
3. EDI3 links choline metabolism to integrin expression, cell adhesion and spreading.
Lesjak MS; Marchan R; Stewart JD; Rempel E; Rahnenführer J; Hengstler JG
Cell Adh Migr; 2014; 8(5):499-508. PubMed ID: 25482527
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Keller M; Rohlf K; Glotzbach A; Leonhardt G; Lüke S; Derksen K; Demirci Ö; Göçener D; AlWahsh M; Lambert J; Lindskog C; Schmidt M; Brenner W; Baumann M; Zent E; Zischinsky ML; Hellwig B; Madjar K; Rahnenführer J; Overbeck N; Reinders J; Cadenas C; Hengstler JG; Edlund K; Marchan R
J Exp Clin Cancer Res; 2023 Jan; 42(1):25. PubMed ID: 36670508
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin and LPA receptor signaling in cancer.
Houben AJ; Moolenaar WH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
[TBL] [Abstract][Full Text] [Related]
6. Agonist-mediated activation of phosphatidylcholine-specific phospholipase C and D in intestinal smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1995 Aug; 48(2):293-304. PubMed ID: 7651363
[TBL] [Abstract][Full Text] [Related]
7. Formation of diacylglycerol by a phospholipase D-phosphatidate phosphatase pathway specific for phosphatidylcholine in endothelial cells.
Martin TW
Biochim Biophys Acta; 1988 Oct; 962(3):282-96. PubMed ID: 2844277
[TBL] [Abstract][Full Text] [Related]
8. Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.
Zhang C; Hwarng G; Cooper DE; Grevengoed TJ; Eaton JM; Natarajan V; Harris TE; Coleman RA
J Biol Chem; 2015 Feb; 290(6):3519-28. PubMed ID: 25512376
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic receptor activation of phosphatidylcholine hydrolysis. Relationship to phosphoinositide hydrolysis and diacylglycerol metabolism.
Martinson EA; Goldstein D; Brown JH
J Biol Chem; 1989 Sep; 264(25):14748-54. PubMed ID: 2549033
[TBL] [Abstract][Full Text] [Related]
10. v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine.
Song JG; Pfeffer LM; Foster DA
Mol Cell Biol; 1991 Oct; 11(10):4903-8. PubMed ID: 1656217
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid activation of phosphatidylcholine-hydrolysing phospholipase D and actin polymerization by a pertussis toxin-sensitive mechanism.
Ha KS; Yeo EJ; Exton JH
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):55-9. PubMed ID: 7945265
[TBL] [Abstract][Full Text] [Related]
12. Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D.
Plevin R; Cook SJ; Palmer S; Wakelam MJ
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):559-65. PubMed ID: 1659382
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms whereby insulin increases diacylglycerol in BC3H-1 myocytes.
Farese RV; Cooper DR; Konda TS; Nair G; Standaert ML; Davis JS; Pollet RJ
Biochem J; 1988 Nov; 256(1):175-84. PubMed ID: 3146971
[TBL] [Abstract][Full Text] [Related]
14. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
15. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.
Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ
Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662
[TBL] [Abstract][Full Text] [Related]
16. Distinct contributions of two choline-producing enzymatic activities to lysophosphatidic acid production in human amniotic fluid from pregnant women in the second trimester and after parturition.
Fukui M; Tsutsumi T; Yamamoto-Mikami A; Morito K; NaokoTakahashi ; Tanaka T; Iwasa T; Kuwahara A; Irahara M; Tokumura A
Prostaglandins Other Lipid Mediat; 2020 Oct; 150():106471. PubMed ID: 32585250
[TBL] [Abstract][Full Text] [Related]
17. Contribution of lipid second messengers to the regulation of phosphatidylcholine synthesis during cell cycle re-entry.
Ng MN; Kitos TE; Cornell RB
Biochim Biophys Acta; 2004 Nov; 1686(1-2):85-99. PubMed ID: 15522825
[TBL] [Abstract][Full Text] [Related]
18. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
[TBL] [Abstract][Full Text] [Related]
20. The ins and outs of lysophosphatidic acid signaling.
Moolenaar WH; van Meeteren LA; Giepmans BN
Bioessays; 2004 Aug; 26(8):870-81. PubMed ID: 15273989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
